

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.82504771 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.82504771 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.61817217 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.61817217 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.31743483 |
| 6 | serine family amino acid catabolic process (GO:0009071) | 5.22783018 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.18079907 |
| 8 | amino-acid betaine metabolic process (GO:0006577) | 5.15793374 |
| 9 | kynurenine metabolic process (GO:0070189) | 4.95180315 |
| 10 | glyoxylate metabolic process (GO:0046487) | 4.93163498 |
| 11 | fatty acid beta-oxidation (GO:0006635) | 4.91121458 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 4.89505494 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.88419342 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.88419342 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.88419342 |
| 16 | regulation of sequestering of triglyceride (GO:0010889) | 4.85826713 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 4.83832933 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81351845 |
| 19 | urea metabolic process (GO:0019627) | 4.71630722 |
| 20 | urea cycle (GO:0000050) | 4.71630722 |
| 21 | lysine catabolic process (GO:0006554) | 4.69139365 |
| 22 | lysine metabolic process (GO:0006553) | 4.69139365 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.68294261 |
| 24 | bile acid biosynthetic process (GO:0006699) | 4.65272944 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.60430818 |
| 26 | cysteine metabolic process (GO:0006534) | 4.58858735 |
| 27 | fatty acid oxidation (GO:0019395) | 4.57309366 |
| 28 | biotin metabolic process (GO:0006768) | 4.53254730 |
| 29 | * fatty acid transmembrane transport (GO:1902001) | 4.49583487 |
| 30 | lipid oxidation (GO:0034440) | 4.48807997 |
| 31 | fatty acid catabolic process (GO:0009062) | 4.47589017 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 4.47226501 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.45834496 |
| 34 | carnitine metabolic process (GO:0009437) | 4.44305166 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 4.43748416 |
| 36 | glycine metabolic process (GO:0006544) | 4.36815126 |
| 37 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.36040910 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.35152641 |
| 39 | * carnitine shuttle (GO:0006853) | 4.32266963 |
| 40 | acylglycerol homeostasis (GO:0055090) | 4.23735344 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.23735344 |
| 42 | bile acid metabolic process (GO:0008206) | 4.20023953 |
| 43 | monocarboxylic acid catabolic process (GO:0072329) | 4.17644772 |
| 44 | branched-chain amino acid catabolic process (GO:0009083) | 4.15912445 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.11850524 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09557569 |
| 47 | regulation of fibrinolysis (GO:0051917) | 4.07844821 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 4.06721339 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 4.06316328 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.02816263 |
| 51 | epoxygenase P450 pathway (GO:0019373) | 4.00348388 |
| 52 | serine family amino acid metabolic process (GO:0009069) | 3.99282753 |
| 53 | ethanol oxidation (GO:0006069) | 3.94011019 |
| 54 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.92406187 |
| 55 | organic acid catabolic process (GO:0016054) | 3.89844198 |
| 56 | carboxylic acid catabolic process (GO:0046395) | 3.89844198 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.89717261 |
| 58 | regulation of protein activation cascade (GO:2000257) | 3.89268759 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 3.88546957 |
| 60 | 2-oxoglutarate metabolic process (GO:0006103) | 3.87612012 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86116269 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.84720184 |
| 63 | protein carboxylation (GO:0018214) | 3.84720184 |
| 64 | bile acid and bile salt transport (GO:0015721) | 3.84217743 |
| 65 | ketone body metabolic process (GO:1902224) | 3.83718789 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 3.83403674 |
| 67 | NADH metabolic process (GO:0006734) | 3.82642599 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.81886455 |
| 69 | coenzyme catabolic process (GO:0009109) | 3.80835034 |
| 70 | complement activation, alternative pathway (GO:0006957) | 3.80129119 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78056883 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76744214 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.76007441 |
| 74 | regulation of cholesterol esterification (GO:0010872) | 3.72468862 |
| 75 | regulation of cholesterol metabolic process (GO:0090181) | 3.65955593 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 3.64573398 |
| 77 | regulation of complement activation (GO:0030449) | 3.62181136 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 3.62077527 |
| 79 | negative regulation of lipase activity (GO:0060192) | 3.61010194 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.59191759 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.59191759 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.59191759 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.58685228 |
| 84 | positive regulation of fatty acid oxidation (GO:0046321) | 3.57319258 |
| 85 | reverse cholesterol transport (GO:0043691) | 3.55208397 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 3.51670291 |
| 87 | phospholipid efflux (GO:0033700) | 3.48162093 |
| 88 | amine catabolic process (GO:0009310) | 3.45463205 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 3.45463205 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.45014957 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.44621455 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.44621455 |
| 93 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.44378358 |
| 94 | indolalkylamine metabolic process (GO:0006586) | 3.40485406 |
| 95 | regulation of fatty acid oxidation (GO:0046320) | 3.39884735 |
| 96 | tricarboxylic acid cycle (GO:0006099) | 3.38108474 |
| 97 | urate metabolic process (GO:0046415) | 3.37975902 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.37524017 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 3.36373385 |
| 100 | negative regulation of sterol transport (GO:0032372) | 3.36373385 |
| 101 | cellular glucuronidation (GO:0052695) | 3.36099606 |
| 102 | arginine metabolic process (GO:0006525) | 3.35667214 |
| 103 | exogenous drug catabolic process (GO:0042738) | 3.31195176 |
| 104 | drug catabolic process (GO:0042737) | 3.31193621 |
| 105 | sterol homeostasis (GO:0055092) | 3.31035655 |
| 106 | small molecule catabolic process (GO:0044282) | 3.29502651 |
| 107 | valine metabolic process (GO:0006573) | 3.28271015 |
| 108 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.23214095 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.20274952 |
| 110 | plasma lipoprotein particle assembly (GO:0034377) | 3.09903664 |
| 111 | cholesterol efflux (GO:0033344) | 3.00900511 |
| 112 | detection of other organism (GO:0098543) | 2.97733252 |
| 113 | drug metabolic process (GO:0017144) | 2.92719849 |
| 114 | neutrophil activation involved in immune response (GO:0002283) | 2.90579699 |
| 115 | uronic acid metabolic process (GO:0006063) | 2.89683683 |
| 116 | glucuronate metabolic process (GO:0019585) | 2.89683683 |
| 117 | omega-hydroxylase P450 pathway (GO:0097267) | 2.89128859 |
| 118 | detection of bacterium (GO:0016045) | 2.88699496 |
| 119 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87520218 |
| 120 | negative regulation of cell killing (GO:0031342) | 2.87520218 |
| 121 | protein-lipid complex assembly (GO:0065005) | 2.87060201 |
| 122 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81241940 |
| 123 | immunoglobulin mediated immune response (GO:0016064) | 2.75329437 |
| 124 | triglyceride catabolic process (GO:0019433) | 2.71330138 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.68930660 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 2.67830366 |
| 127 | diacylglycerol metabolic process (GO:0046339) | 2.65252750 |
| 128 | angiotensin maturation (GO:0002003) | 2.64503378 |
| 129 | detection of external biotic stimulus (GO:0098581) | 2.63781677 |
| 130 | acute-phase response (GO:0006953) | 2.63138722 |
| 131 | acylglycerol catabolic process (GO:0046464) | 2.59289606 |
| 132 | neutral lipid catabolic process (GO:0046461) | 2.59289606 |
| 133 | low-density lipoprotein particle remodeling (GO:0034374) | 2.57947250 |
| 134 | lipoprotein transport (GO:0042953) | 2.57924753 |
| 135 | protein-lipid complex subunit organization (GO:0071825) | 2.57920192 |
| 136 | hormone catabolic process (GO:0042447) | 2.57706653 |
| 137 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57006305 |
| 138 | xenobiotic catabolic process (GO:0042178) | 2.55064165 |
| 139 | ethanol metabolic process (GO:0006067) | 2.54359318 |
| 140 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.51842400 |
| 141 | cytolysis (GO:0019835) | 2.45775125 |
| 142 | cytidine metabolic process (GO:0046087) | 2.43835436 |
| 143 | cytidine catabolic process (GO:0006216) | 2.43835436 |
| 144 | cytidine deamination (GO:0009972) | 2.43835436 |
| 145 | blood coagulation, intrinsic pathway (GO:0007597) | 2.41948764 |
| 146 | protein activation cascade (GO:0072376) | 2.39752773 |
| 147 | glycosphingolipid catabolic process (GO:0046479) | 2.36781203 |
| 148 | complement activation (GO:0006956) | 2.36103534 |
| 149 | fructose metabolic process (GO:0006000) | 2.36087099 |
| 150 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.34775552 |
| 151 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.33469971 |
| 152 | very long-chain fatty acid metabolic process (GO:0000038) | 2.31696658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.59009895 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.79992145 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.60347478 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.96807160 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.92599328 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.31279028 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30453608 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.12663710 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.57938306 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.31145341 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.23846924 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.34143194 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30232206 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22743783 |
| 15 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.14689885 |
| 16 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.64175322 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52596760 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46434382 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34362573 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.28358217 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21290117 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.21271234 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19891311 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13502320 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06154097 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98922955 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.98093436 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92383908 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.91986650 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85673427 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.83950428 |
| 32 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76466370 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76458582 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73976769 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.73773326 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66190995 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63267713 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61317580 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61218249 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57568722 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54357256 |
| 42 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.53014219 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49888152 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.49000071 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46847630 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.42885246 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40657005 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36761752 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36507688 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36141187 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35826692 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.34082898 |
| 53 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33808897 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33306660 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32824235 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32251829 |
| 57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30506566 |
| 58 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29798741 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28855490 |
| 60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28131232 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28017195 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27576658 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27147178 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24108240 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21313977 |
| 66 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.20981013 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20850118 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19628938 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19333018 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19284501 |
| 71 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.18151942 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17639969 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16630077 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16018000 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12365817 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12082974 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11773096 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08109678 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07854893 |
| 80 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07564970 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07277302 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07193382 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06085843 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05791712 |
| 85 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04339499 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01805476 |
| 87 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01308808 |
| 88 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99538731 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.99427804 |
| 90 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98779084 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98622989 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95554040 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94954673 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94120014 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92641544 |
| 96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.92506100 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91997876 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91797277 |
| 99 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91509228 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90264000 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 0.90033027 |
| 102 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.89631511 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89368871 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87159963 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86818229 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85198737 |
| 107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83394518 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83060597 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82626871 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82282314 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82187477 |
| 112 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81700500 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81045425 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80969491 |
| 115 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80968049 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80280660 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80156533 |
| 118 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.79692848 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78855052 |
| 120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78468083 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78444292 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77660465 |
| 123 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77396019 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76900986 |
| 125 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.76065102 |
| 126 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74000910 |
| 127 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.73703304 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71184931 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70884796 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.70862683 |
| 131 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.70138047 |
| 132 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.69607335 |
| 133 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.69526607 |
| 134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.68838474 |
| 135 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.68596187 |
| 136 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.67749748 |
| 137 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67730155 |
| 138 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.67715598 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.66997379 |
| 140 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66139648 |
| 141 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.65812876 |
| 142 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.65269076 |
| 143 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.64505167 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64460329 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.64051299 |
| 146 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63564702 |
| 147 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.63211535 |
| 148 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.62638868 |
| 149 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.62529063 |
| 150 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.61663307 |
| 151 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.61354453 |
| 152 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.61318883 |
| 153 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.59288825 |
| 154 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.59288825 |
| 155 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.59288825 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58923557 |
| 157 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.58630491 |
| 158 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58547869 |
| 159 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58541415 |
| 160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57989539 |
| 161 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57989539 |
| 162 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.57787203 |
| 163 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.57508102 |
| 164 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57495336 |
| 165 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.57310118 |
| 166 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.57287992 |
| 167 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.56919472 |
| 168 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56822753 |
| 169 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56750568 |
| 170 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.56273606 |
| 171 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.55851328 |
| 172 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.55314254 |
| 173 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.55192391 |
| 174 | NFYA_21822215_ChIP-Seq_K562_Human | 0.54349861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.53412321 |
| 2 | MP0005360_urolithiasis | 5.69181048 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.53010393 |
| 4 | MP0005365_abnormal_bile_salt | 5.36692224 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.17554879 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07603526 |
| 7 | MP0005451_abnormal_body_composition | 3.47983419 |
| 8 | MP0009840_abnormal_foam_cell | 3.15865981 |
| 9 | MP0003252_abnormal_bile_duct | 3.01103470 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.00763623 |
| 11 | MP0005670_abnormal_white_adipose | 2.91603940 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.73699602 |
| 13 | MP0005332_abnormal_amino_acid | 2.64607070 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.41237225 |
| 15 | MP0009785_altered_susceptibility_to | 2.27229093 |
| 16 | MP0003646_muscle_fatigue | 2.22102693 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11483932 |
| 18 | MP0003195_calcinosis | 2.11288127 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.11253319 |
| 20 | MP0003436_decreased_susceptibility_to | 2.08425703 |
| 21 | MP0005671_abnormal_response_to | 2.05509942 |
| 22 | MP0000609_abnormal_liver_physiology | 2.05064301 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.04926699 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.04657985 |
| 25 | MP0006082_CNS_inflammation | 2.00703306 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.97407388 |
| 27 | MP0005025_abnormal_response_to | 1.95315484 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.93041022 |
| 29 | MP0002419_abnormal_innate_immunity | 1.91743991 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.85448822 |
| 31 | MP0004130_abnormal_muscle_cell | 1.82609915 |
| 32 | MP0000685_abnormal_immune_system | 1.80275113 |
| 33 | MP0005083_abnormal_biliary_tract | 1.80186151 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.77153031 |
| 35 | MP0001800_abnormal_humoral_immune | 1.77100166 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.74284677 |
| 37 | MP0001790_abnormal_immune_system | 1.73137182 |
| 38 | MP0005387_immune_system_phenotype | 1.73137182 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.68329520 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.65453126 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.62910257 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.60804322 |
| 43 | MP0003868_abnormal_feces_composition | 1.58111345 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.56587294 |
| 45 | MP0002971_abnormal_brown_adipose | 1.55372022 |
| 46 | MP0002723_abnormal_immune_serum | 1.55037313 |
| 47 | MP0003303_peritoneal_inflammation | 1.54335982 |
| 48 | MP0003718_maternal_effect | 1.53418663 |
| 49 | MP0001661_extended_life_span | 1.53334507 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.50540361 |
| 51 | MP0002132_abnormal_respiratory_system | 1.44667491 |
| 52 | MP0001764_abnormal_homeostasis | 1.44202575 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.42789489 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.42498958 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.41484239 |
| 56 | MP0001819_abnormal_immune_cell | 1.39722377 |
| 57 | MP0003186_abnormal_redox_activity | 1.37812396 |
| 58 | MP0005330_cardiomyopathy | 1.36986043 |
| 59 | MP0000604_amyloidosis | 1.36954506 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.36483529 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.30685250 |
| 62 | MP0003075_altered_response_to | 1.28230519 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25696698 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.24303634 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.23394829 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.23169030 |
| 67 | MP0003011_delayed_dark_adaptation | 1.22757412 |
| 68 | MP0005647_abnormal_sex_gland | 1.22013678 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.18550492 |
| 70 | MP0009697_abnormal_copulation | 1.15728326 |
| 71 | MP0000343_altered_response_to | 1.15145838 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.14258827 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.13935785 |
| 74 | MP0005166_decreased_susceptibility_to | 1.12656475 |
| 75 | MP0003866_abnormal_defecation | 1.10195761 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.07693398 |
| 77 | MP0005266_abnormal_metabolism | 1.07415781 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.05265891 |
| 79 | MP0000716_abnormal_immune_system | 1.03982864 |
| 80 | MP0002405_respiratory_system_inflammati | 1.02955159 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.99006987 |
| 82 | MP0004036_abnormal_muscle_relaxation | 0.97593202 |
| 83 | MP0004147_increased_porphyrin_level | 0.95439721 |
| 84 | MP0000858_altered_metastatic_potential | 0.94872141 |
| 85 | MP0006138_congestive_heart_failure | 0.94556302 |
| 86 | MP0002398_abnormal_bone_marrow | 0.94538146 |
| 87 | MP0000689_abnormal_spleen_morphology | 0.94022874 |
| 88 | MP0000566_synostosis | 0.93556838 |
| 89 | MP0005408_hypopigmentation | 0.92346425 |
| 90 | MP0004381_abnormal_hair_follicle | 0.92048201 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.91677487 |
| 92 | MP0000598_abnormal_liver_morphology | 0.91415711 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90818032 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.90252545 |
| 95 | MP0005395_other_phenotype | 0.89777291 |
| 96 | MP0003950_abnormal_plasma_membrane | 0.87175736 |
| 97 | MP0002269_muscular_atrophy | 0.87149384 |
| 98 | MP0002722_abnormal_immune_system | 0.85806588 |
| 99 | MP0005165_increased_susceptibility_to | 0.84948890 |
| 100 | MP0004883_abnormal_blood_vessel | 0.84260475 |
| 101 | MP0005334_abnormal_fat_pad | 0.83893201 |
| 102 | MP0009763_increased_sensitivity_to | 0.82730832 |
| 103 | MP0002429_abnormal_blood_cell | 0.82151666 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.82097082 |
| 105 | MP0009115_abnormal_fat_cell | 0.80932980 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.80272399 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.80266244 |
| 108 | MP0000749_muscle_degeneration | 0.80080313 |
| 109 | MP0004947_skin_inflammation | 0.80037755 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.79494833 |
| 111 | MP0001545_abnormal_hematopoietic_system | 0.79494833 |
| 112 | MP0002006_tumorigenesis | 0.79189664 |
| 113 | MP0005535_abnormal_body_temperature | 0.77929090 |
| 114 | MP0005164_abnormal_response_to | 0.77762672 |
| 115 | MP0000249_abnormal_blood_vessel | 0.76867931 |
| 116 | MP0005385_cardiovascular_system_phenoty | 0.76767735 |
| 117 | MP0001544_abnormal_cardiovascular_syste | 0.76767735 |
| 118 | MP0001851_eye_inflammation | 0.76090484 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.75592192 |
| 120 | MP0004087_abnormal_muscle_fiber | 0.73096984 |
| 121 | MP0008260_abnormal_autophagy | 0.72987356 |
| 122 | MP0000579_abnormal_nail_morphology | 0.70899114 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.69462263 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.69038042 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.67747857 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.67444452 |
| 127 | MP0002796_impaired_skin_barrier | 0.67016120 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.66964329 |
| 129 | MP0002254_reproductive_system_inflammat | 0.65805266 |
| 130 | MP0009764_decreased_sensitivity_to | 0.63200255 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.63076844 |
| 132 | MP0002970_abnormal_white_adipose | 0.62443193 |
| 133 | MP0002972_abnormal_cardiac_muscle | 0.62182698 |
| 134 | MP0005636_abnormal_mineral_homeostasis | 0.62034085 |
| 135 | MP0000750_abnormal_muscle_regeneration | 0.60023732 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.57889911 |
| 137 | MP0001756_abnormal_urination | 0.57574969 |
| 138 | MP0002127_abnormal_cardiovascular_syste | 0.56737433 |
| 139 | MP0000462_abnormal_digestive_system | 0.56021891 |
| 140 | MP0008469_abnormal_protein_level | 0.52828629 |
| 141 | MP0000747_muscle_weakness | 0.52315149 |
| 142 | MP0005448_abnormal_energy_balance | 0.51552758 |
| 143 | MP0000751_myopathy | 0.48136726 |
| 144 | MP0003690_abnormal_glial_cell | 0.47788886 |
| 145 | MP0003828_pulmonary_edema | 0.46833242 |
| 146 | MP0004043_abnormal_pH_regulation | 0.46542690 |
| 147 | MP0002106_abnormal_muscle_physiology | 0.46469697 |
| 148 | MP0002060_abnormal_skin_morphology | 0.44912712 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.44075633 |
| 150 | MP0003699_abnormal_female_reproductive | 0.43352374 |
| 151 | MP0003724_increased_susceptibility_to | 0.40820823 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.39761268 |
| 153 | MP0000230_abnormal_systemic_arterial | 0.39664677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.97680846 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.62996570 |
| 3 | Hyperglycinemia (HP:0002154) | 5.35157389 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.34076655 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 5.34076655 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.17105409 |
| 7 | Xanthomatosis (HP:0000991) | 5.06425978 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.87672618 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.84289155 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.77929147 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.72456250 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.71566716 |
| 13 | * Hyperammonemia (HP:0001987) | 4.70533586 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.66063133 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.45003054 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.42971717 |
| 17 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.29829425 |
| 18 | * Dicarboxylic aciduria (HP:0003215) | 4.29829425 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.19607682 |
| 20 | Ketosis (HP:0001946) | 4.19316670 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.18649356 |
| 22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.01025576 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.90666542 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.87228000 |
| 25 | Abnormality of serum amino acid levels (HP:0003112) | 3.77306946 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.73121820 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.67132576 |
| 28 | Epidermoid cyst (HP:0200040) | 3.67081214 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.62736595 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.45135324 |
| 31 | * Lethargy (HP:0001254) | 3.38089024 |
| 32 | Cerebral edema (HP:0002181) | 3.36935041 |
| 33 | Gingival bleeding (HP:0000225) | 3.33444223 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32157215 |
| 35 | Complement deficiency (HP:0004431) | 3.31083506 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.28604604 |
| 37 | Ketoacidosis (HP:0001993) | 3.28260614 |
| 38 | Joint hemorrhage (HP:0005261) | 3.14119725 |
| 39 | Abnormality of macrophages (HP:0004311) | 3.10525463 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.09328280 |
| 41 | Renal cortical cysts (HP:0000803) | 3.06176557 |
| 42 | Myoglobinuria (HP:0002913) | 3.01828952 |
| 43 | Metabolic acidosis (HP:0001942) | 2.96457945 |
| 44 | Fat malabsorption (HP:0002630) | 2.89404385 |
| 45 | Proximal tubulopathy (HP:0000114) | 2.84132630 |
| 46 | Gout (HP:0001997) | 2.80649065 |
| 47 | * Rhabdomyolysis (HP:0003201) | 2.78126723 |
| 48 | Nausea (HP:0002018) | 2.76748398 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70252578 |
| 50 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.68675005 |
| 51 | Hypercholesterolemia (HP:0003124) | 2.66815873 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66585055 |
| 53 | Hepatic necrosis (HP:0002605) | 2.65030533 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.64671274 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 2.63997504 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.62669409 |
| 57 | Glomerulonephritis (HP:0000099) | 2.61128994 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.60324888 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.60324888 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.60324888 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.56163142 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51980720 |
| 63 | Obstructive lung disease (HP:0006536) | 2.51980720 |
| 64 | Hyperglycemia (HP:0003074) | 2.51867749 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.50565236 |
| 66 | Myocardial infarction (HP:0001658) | 2.47930605 |
| 67 | Meningitis (HP:0001287) | 2.44307815 |
| 68 | Hyperuricemia (HP:0002149) | 2.40953621 |
| 69 | Increased purine levels (HP:0004368) | 2.40953621 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.38307321 |
| 71 | Purpura (HP:0000979) | 2.37959261 |
| 72 | Vomiting (HP:0002013) | 2.36943426 |
| 73 | Cerebral palsy (HP:0100021) | 2.36362108 |
| 74 | Right ventricular cardiomyopathy (HP:0011663) | 2.34988559 |
| 75 | Epistaxis (HP:0000421) | 2.34833619 |
| 76 | Myositis (HP:0100614) | 2.32518888 |
| 77 | Spontaneous abortion (HP:0005268) | 2.32024890 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.28857176 |
| 79 | Joint swelling (HP:0001386) | 2.28054634 |
| 80 | Gingivitis (HP:0000230) | 2.27258021 |
| 81 | Skin nodule (HP:0200036) | 2.26017092 |
| 82 | Amyloidosis (HP:0011034) | 2.24747033 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.23590269 |
| 84 | Asymmetric septal hypertrophy (HP:0001670) | 2.21435516 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20814342 |
| 86 | Abnormality of complement system (HP:0005339) | 2.18843128 |
| 87 | Abnormal cartilage morphology (HP:0002763) | 2.16337871 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.16110863 |
| 89 | Exercise-induced myalgia (HP:0003738) | 2.15016867 |
| 90 | Petechiae (HP:0000967) | 2.14553062 |
| 91 | Nemaline bodies (HP:0003798) | 2.14530087 |
| 92 | Steatorrhea (HP:0002570) | 2.14422022 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.13761002 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.13672330 |
| 95 | Increased muscle lipid content (HP:0009058) | 2.12020958 |
| 96 | Dysostosis multiplex (HP:0000943) | 2.10735608 |
| 97 | Sensorimotor neuropathy (HP:0007141) | 2.10067065 |
| 98 | Muscle fiber inclusion bodies (HP:0100299) | 2.09478952 |
| 99 | Muscle fiber splitting (HP:0003555) | 2.09095686 |
| 100 | Increased serum ferritin (HP:0003281) | 2.08939868 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 2.08267713 |
| 102 | Glycosuria (HP:0003076) | 2.08267713 |
| 103 | Hepatocellular carcinoma (HP:0001402) | 2.08050410 |
| 104 | Orchitis (HP:0100796) | 2.07325178 |
| 105 | Acute encephalopathy (HP:0006846) | 2.07244743 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 2.07043546 |
| 107 | Hydroxyprolinuria (HP:0003080) | 2.07043546 |
| 108 | Chronic diarrhea (HP:0002028) | 2.06557070 |
| 109 | Brushfield spots (HP:0001088) | 2.06330457 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.05603873 |
| 111 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04512441 |
| 112 | Methylmalonic aciduria (HP:0012120) | 2.03142050 |
| 113 | Abnormality of T cell number (HP:0011839) | 2.02824500 |
| 114 | Granulocytopenia (HP:0001913) | 2.02416822 |
| 115 | Abnormality of glycolysis (HP:0004366) | 2.02325010 |
| 116 | Increased serum pyruvate (HP:0003542) | 2.02325010 |
| 117 | Malnutrition (HP:0004395) | 2.01218165 |
| 118 | Pancreatitis (HP:0001733) | 2.01153538 |
| 119 | Thrombophlebitis (HP:0004418) | 2.01135514 |
| 120 | Mucopolysacchariduria (HP:0008155) | 2.00954840 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00954840 |
| 122 | T lymphocytopenia (HP:0005403) | 2.00566188 |
| 123 | Autoimmune hemolytic anemia (HP:0001890) | 2.00139772 |
| 124 | Pulmonary embolism (HP:0002204) | 2.00093016 |
| 125 | Prolonged bleeding time (HP:0003010) | 1.99982690 |
| 126 | Recurrent skin infections (HP:0001581) | 1.99859718 |
| 127 | Vasculitis (HP:0002633) | 1.99836383 |
| 128 | Abnormality of lateral ventricle (HP:0030047) | 1.99618582 |
| 129 | Skin rash (HP:0000988) | 1.98645396 |
| 130 | Chest pain (HP:0100749) | 1.98524965 |
| 131 | Hypoglycemic seizures (HP:0002173) | 1.98408305 |
| 132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98042492 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98042492 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98042492 |
| 135 | Hypertriglyceridemia (HP:0002155) | 1.97591583 |
| 136 | Vascular calcification (HP:0004934) | 1.97016893 |
| 137 | Lactic acidosis (HP:0003128) | 1.94561783 |
| 138 | Encephalitis (HP:0002383) | 1.94439712 |
| 139 | * Ventricular tachycardia (HP:0004756) | 1.93968932 |
| 140 | Sudden death (HP:0001699) | 1.92893070 |
| 141 | * Irritability (HP:0000737) | 1.92640802 |
| 142 | Periodontitis (HP:0000704) | 1.91998981 |
| 143 | Eosinophilia (HP:0001880) | 1.91001862 |
| 144 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88490088 |
| 145 | Nephritis (HP:0000123) | 1.88229477 |
| 146 | Hypoproteinemia (HP:0003075) | 1.87859630 |
| 147 | Abnormality of vitamin metabolism (HP:0100508) | 1.86906859 |
| 148 | Reduced antithrombin III activity (HP:0001976) | 1.86473875 |
| 149 | Urticaria (HP:0001025) | 1.86391878 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86206866 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.85933844 |
| 152 | Autoimmune thrombocytopenia (HP:0001973) | 1.85587575 |
| 153 | Hemoptysis (HP:0002105) | 1.85507563 |
| 154 | Increased IgM level (HP:0003496) | 1.85353428 |
| 155 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84984329 |
| 156 | Palpitations (HP:0001962) | 1.84612720 |
| 157 | Hemorrhage of the eye (HP:0011885) | 1.84472908 |
| 158 | Respiratory distress (HP:0002098) | 1.83905694 |
| 159 | * Atrioventricular block (HP:0001678) | 1.81859935 |
| 160 | Esophageal varix (HP:0002040) | 1.81333760 |
| 161 | Hyporeflexia of lower limbs (HP:0002600) | 1.79793870 |
| 162 | * Elevated hepatic transaminases (HP:0002910) | 1.77749316 |
| 163 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77595401 |
| 164 | Abnormality of the gallbladder (HP:0005264) | 1.74465787 |
| 165 | Acute hepatic failure (HP:0006554) | 1.71277240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.53550407 |
| 2 | LATS1 | 3.49790947 |
| 3 | STK38L | 3.20104494 |
| 4 | RIPK4 | 3.16012740 |
| 5 | PDK4 | 3.01785660 |
| 6 | PDK3 | 3.01785660 |
| 7 | MAP4K1 | 2.60197903 |
| 8 | BLK | 2.51843525 |
| 9 | TXK | 2.49294487 |
| 10 | LATS2 | 2.41845147 |
| 11 | CDK12 | 2.34104755 |
| 12 | ERBB4 | 2.32147258 |
| 13 | MST1R | 2.20552540 |
| 14 | TESK2 | 2.19047977 |
| 15 | ZAP70 | 2.07550235 |
| 16 | FGFR4 | 2.06827396 |
| 17 | JAK3 | 2.02883082 |
| 18 | SIK1 | 1.95197411 |
| 19 | IRAK3 | 1.94710385 |
| 20 | INSRR | 1.93365720 |
| 21 | PINK1 | 1.92511477 |
| 22 | AKT3 | 1.92017214 |
| 23 | PDK2 | 1.90692336 |
| 24 | OBSCN | 1.88884871 |
| 25 | FES | 1.85542313 |
| 26 | PRKAA2 | 1.80010660 |
| 27 | SCYL2 | 1.74397409 |
| 28 | SYK | 1.73161357 |
| 29 | TTK | 1.68474232 |
| 30 | GRK6 | 1.65410387 |
| 31 | CSK | 1.60712362 |
| 32 | STK3 | 1.55934872 |
| 33 | TBK1 | 1.55639875 |
| 34 | EPHA2 | 1.54569300 |
| 35 | MUSK | 1.54089809 |
| 36 | CAMK1D | 1.53620349 |
| 37 | ZAK | 1.51163500 |
| 38 | MAPK11 | 1.47824532 |
| 39 | TTN | 1.46682657 |
| 40 | JAK1 | 1.43462498 |
| 41 | MAP3K14 | 1.43241956 |
| 42 | BUB1 | 1.41670029 |
| 43 | ITK | 1.41036895 |
| 44 | PRPF4B | 1.40754305 |
| 45 | KIT | 1.40351337 |
| 46 | BTK | 1.39925073 |
| 47 | MET | 1.37743000 |
| 48 | PIK3CA | 1.36079412 |
| 49 | PLK4 | 1.35489630 |
| 50 | TNK2 | 1.33368526 |
| 51 | ABL2 | 1.27195113 |
| 52 | TEC | 1.22213058 |
| 53 | LYN | 1.21100534 |
| 54 | PRKAA1 | 1.20970020 |
| 55 | TIE1 | 1.19530079 |
| 56 | MAPKAPK3 | 1.18910094 |
| 57 | CSF1R | 1.17988522 |
| 58 | MAP3K11 | 1.17578621 |
| 59 | LCK | 1.10065179 |
| 60 | PIM2 | 1.03894846 |
| 61 | MAP3K6 | 0.98695909 |
| 62 | TGFBR2 | 0.97146372 |
| 63 | PDK1 | 0.94882069 |
| 64 | IKBKE | 0.94301390 |
| 65 | TESK1 | 0.94256400 |
| 66 | HCK | 0.92441473 |
| 67 | IRAK4 | 0.91283197 |
| 68 | BMPR2 | 0.91092142 |
| 69 | STK4 | 0.90550123 |
| 70 | MAP3K13 | 0.89691126 |
| 71 | MAP2K3 | 0.88276500 |
| 72 | TAOK3 | 0.85934493 |
| 73 | PBK | 0.83552111 |
| 74 | FGFR3 | 0.83469870 |
| 75 | IKBKB | 0.82817049 |
| 76 | ERN1 | 0.82644491 |
| 77 | MAP3K1 | 0.82634714 |
| 78 | KDR | 0.82320826 |
| 79 | NEK1 | 0.81598382 |
| 80 | GRK1 | 0.81122176 |
| 81 | WEE1 | 0.80500995 |
| 82 | PRKG2 | 0.80341821 |
| 83 | MAP3K3 | 0.78946486 |
| 84 | TYK2 | 0.78759281 |
| 85 | DYRK3 | 0.78351004 |
| 86 | PIK3CG | 0.78349969 |
| 87 | CAMKK2 | 0.77940533 |
| 88 | LRRK2 | 0.77683712 |
| 89 | STK24 | 0.77387483 |
| 90 | MAPK7 | 0.77045067 |
| 91 | PHKG1 | 0.76224695 |
| 92 | PHKG2 | 0.76224695 |
| 93 | MAP2K4 | 0.75274524 |
| 94 | GRK7 | 0.73376412 |
| 95 | FLT3 | 0.72837242 |
| 96 | PRKCQ | 0.71545802 |
| 97 | MYLK | 0.70909301 |
| 98 | BRD4 | 0.70534053 |
| 99 | NME2 | 0.70350661 |
| 100 | MATK | 0.69347443 |
| 101 | RPS6KB2 | 0.68670982 |
| 102 | EIF2AK2 | 0.68178185 |
| 103 | FGR | 0.67701321 |
| 104 | MAPK12 | 0.67608051 |
| 105 | MAP2K2 | 0.67572715 |
| 106 | LMTK2 | 0.65578069 |
| 107 | KSR2 | 0.65267709 |
| 108 | NEK2 | 0.64530855 |
| 109 | ACVR1B | 0.64455983 |
| 110 | TRIB3 | 0.64433985 |
| 111 | STK38 | 0.64142826 |
| 112 | PKN1 | 0.64076901 |
| 113 | TAOK2 | 0.63319265 |
| 114 | CDK9 | 0.62355456 |
| 115 | MELK | 0.62113702 |
| 116 | MTOR | 0.59523570 |
| 117 | PAK3 | 0.58622129 |
| 118 | EPHA3 | 0.58546988 |
| 119 | DYRK1B | 0.57864927 |
| 120 | MAP3K5 | 0.57236845 |
| 121 | BRAF | 0.56123037 |
| 122 | MAP3K12 | 0.55913063 |
| 123 | TAOK1 | 0.55434001 |
| 124 | CDK6 | 0.54990352 |
| 125 | CDK4 | 0.53713770 |
| 126 | PIM1 | 0.53006280 |
| 127 | NLK | 0.52763418 |
| 128 | SRPK1 | 0.50377380 |
| 129 | EPHB1 | 0.49191107 |
| 130 | PLK1 | 0.48348656 |
| 131 | IGF1R | 0.48294898 |
| 132 | PRKACG | 0.47940301 |
| 133 | AURKB | 0.47216360 |
| 134 | EIF2AK3 | 0.46862794 |
| 135 | CAMK2G | 0.44479305 |
| 136 | PDPK1 | 0.44111188 |
| 137 | MAP3K2 | 0.43803058 |
| 138 | NEK9 | 0.43359880 |
| 139 | MAPK4 | 0.42799858 |
| 140 | STK16 | 0.42742782 |
| 141 | MAP2K1 | 0.41946999 |
| 142 | FYN | 0.41461761 |
| 143 | MAP3K7 | 0.40988113 |
| 144 | CAMK1G | 0.40530140 |
| 145 | MAP2K6 | 0.40505361 |
| 146 | GSK3A | 0.40143533 |
| 147 | CHEK2 | 0.39948490 |
| 148 | ICK | 0.39142025 |
| 149 | STK39 | 0.38615798 |
| 150 | FGFR2 | 0.38062117 |
| 151 | JAK2 | 0.36715382 |
| 152 | PRKD1 | 0.36597740 |
| 153 | IRAK1 | 0.36431341 |
| 154 | PRKCD | 0.35053496 |
| 155 | MAPKAPK2 | 0.35014424 |
| 156 | RPS6KC1 | 0.34348735 |
| 157 | IRAK2 | 0.34343915 |
| 158 | CDK7 | 0.34047319 |
| 159 | AKT2 | 0.33785999 |
| 160 | CAMK2D | 0.33638732 |
| 161 | TRPM7 | 0.32652830 |
| 162 | DYRK2 | 0.31085260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31339163 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.21522957 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08699696 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.96530539 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86452279 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.58703092 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58364609 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48303996 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45206684 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41288672 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40154499 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40085631 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34405389 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.31791504 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.29923930 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19549712 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.18453373 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.13317263 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.04379997 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.93715274 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.92990621 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.92103319 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85697631 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.84661758 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84244707 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80859989 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80723970 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.79505611 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76898862 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.73960674 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73466191 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66026775 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65109153 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64285954 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60650812 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56775021 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55834179 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47701472 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45601653 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44878491 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42151341 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41378639 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40443625 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40008196 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39247574 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35790752 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.34058057 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30632223 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29714660 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29610293 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28986519 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24691514 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22763642 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18542132 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17008690 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13230097 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11876116 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07679249 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07540855 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05654005 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05047319 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03445230 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02661749 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 1.00035471 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99961878 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98587278 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.98292444 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.96620974 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92068251 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90744552 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89125406 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.88669987 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.85595507 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84040355 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79818421 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79421373 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78780309 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77832640 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77665782 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75481763 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.74846141 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72818257 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69999580 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.68204066 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68054091 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67802060 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67726207 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.67342856 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66427429 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64649480 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63380417 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.62107221 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58233150 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55521239 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55301387 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51951397 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51908826 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48223357 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.44463555 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42407893 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41982563 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40637019 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37948468 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37654221 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37413772 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36827963 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32959224 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31768527 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30535625 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29682228 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.28470531 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28208428 |
| 113 | RNA polymerase_Homo sapiens_hsa03020 | 0.26533176 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26375237 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23468209 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20456438 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17691020 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12764476 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11480763 |
| 120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.09328149 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.08717866 |
| 122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.07688589 |
| 123 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.05246291 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0892324 |
| 125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.0856499 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0758624 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | -0.0516472 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | -0.0270073 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0243036 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | -0.0226688 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0027450 |

